v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue    
Total revenue $ 1,030,193 $ 9,784
Cost of revenues 295,799 0
Operating expenses    
Selling, general and administrative 8,763,376 9,156,061
Research and development 5,523,352 14,305,208
Total operating expenses 14,286,728 23,461,269
Loss from operations (13,552,334) (23,451,485)
Other income (expense)    
Sale of royalty and milestone rights, net of transaction costs (Note 13) 0 20,379,376
Other income (expense) 153,060 (981,490)
Net loss (13,399,274) (4,053,599)
Net loss to common stockholders (13,399,274) (4,053,599)
Foreign currency translation adjustments 7,186 (67,913)
Comprehensive loss $ (13,392,088) $ (4,121,512)
Loss per common share - basic (in usd per share) $ (1.20) $ (0.48)
Loss per common share - diluted (in usd per share) $ (1.20) $ (0.48)
Weighted average number of common shares outstanding:    
Basic (in shares) 11,178,752 8,497,459
Diluted (in shares) 11,178,752 8,497,459
License fee revenue and other revenue    
Revenue    
Total revenue $ 1,030,193 $ 9,784